Mary Luz
Uribe
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (1)
2021
-
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
EMBO Molecular Medicine, Vol. 13, Núm. 4